PARIS--(BUSINESS WIRE)--France Biotech, (www.france-biotech.org), an association of entrepreneurs in the life sciences industry, today announced the high level of interest in the first edition of “French Life Sciences Days” on June 25th and 26th in New York and is pleased to announce the event renewal next year on June 17th and 18th in New York.
This brand new initiative allowed 19 Life Sciences companies, recently listed or more mature, with a market capitalization from Euro 25 to 477 million, developing Biotech and Medtech breakthrough technologies with advanced clinical results or sales. Their CEOs have displayed their business plans to 50 American non-specialized and specialized financial investors.
Our firms’ investment opportunities have attracted prestigious names of
Finance from Boston, New York and Philadelphia. These investors showed a
tremendous interest in the 19 innovative companies during 70 one-to-one
meetings (about 4 meetings per company).
This first edition has also been broadly covered in French and American media (Forbes, The Wall Street Journal: http://on.wsj.com/1wBk3UW, Reuters, Les Echos, La Tribune, and a specific coverage from BFM Business).
“The Life Sciences Days are a major element in promoting and reinforcing the whole innovative SMEs funding scene, from startup to more mature companies. Our goal has been achieved: French innovation in the healthcare field has been recognized in the United States and the investors are convinced that world future champions are among us! The French financial players confirm Euronext’s leading position. This event’s success calls for further ones and we will renew this event on June 17th and 18th 2015 in New York and already plan the same initiative in Asia. I particularly thank our sponsors, Bryan Garnier & Co, Société Générale, Invest Securities, Deloitte, Mazars and NewCap who have been key to this success!”, Pierre-Olivier Goineau, the president of France Biotech, said.
About the “French Life Sciences Days”
This new initiative by France Biotech aims at fostering and boosting the connections between French public companies and investors worldwide in an effort to facilitate exchanges and demonstrate the solidity of our own financial community. The first edition will be held in New York. This “French Life Sciences Days” initiative brings together key Parisian players (banks, brokers, analysts, auditors, lawyers and communication agencies) to form a sponsorship committee that will support entrepreneurs in the life sciences. During this occasion, the French biotech and medtech companies listed on the NYSE Euronext exchange will introduce themselves to international investors.
About France Biotech
France Biotech brings together the main French life science companies and their expert partners. Its mission is to support the development of the French life sciences by advocating for a favorable regulatory and fiscal environment. In 2004, France Biotech successfully lobbied the French government to create a special fiscal status for innovative start-ups and continues to act as an advocate for the French innovative sector. The organization is currently chaired by Pierre-Olivier Goineau, Co-Founder and CEO of ERYTECH Pharma. France Biotech has over 150 members and its board of directors is composed of 20 entrepreneurs in the life sciences.